Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
ObjectivesTo evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer (ERSPC), 1 United Kingdom, 1 Austrian, and 3 US biopsy cohorts.MethodsPCPTRC risks were calculated for 25,733 biopsies using prostate-specific antigen (PSA), digital rectal examination, family history, history of prior biopsy, and imputation for missing covariates. Predictions were evaluated using the areas underneath the receiver operating characteristic curves (AUC), discrimination slopes, chi-square tests of goodness of fit, and net benefit decision curves.ResultsAUCs of the PCPTRC ranged from a low of 56% in the ERSPC Goeteborg Rounds 2–6 cohort to a high of 72% in the ERSPC Goeteborg Round 1 cohort and were statistically significantly higher than that of PSA in 6 out of the 10 cohorts. The PCPTRC was well calibrated in the SABOR, Tyrol, and Durham cohorts. There was limited to no net benefit to using the PCPTRC for biopsy referral compared to biopsying all or no men in all five ERSPC cohorts and benefit within a limited range of risk thresholds in all other cohorts.ConclusionsExternal validation of the PCPTRC across ten cohorts revealed varying degree of success highly dependent on the cohort, most likely due to different criteria for and work-up before biopsy. Future validation studies of new calculators for prostate cancer should acknowledge the potential impact of the specific cohort studied when reporting successful versus failed validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341 · cited 1×
“Net benefit curves were computed by calculating for each possible PCPTRC risk of a positive biopsy (p) ranging from 0 to 100%, sensitivity 9 %cancer - false-positive rate 9 %noncancer 9 [p/(1 - p)], and were assessed for their gain over the corresponding net benefit curves of referring no patients to biopsy (horizonta…”
MethodSelf-citationClinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Multiple imputation of discrete and continuous data by fully conditional specification
van Buuren, S. (2007) · Statistical Methods in Medical Research · doi:10.1177/0962280206074463 · Cited by 2,827 · cited 1×
“The number of iterations was set to 20, and PCPTRC risks were computed as the average over five imputations of the missing risk factor [3, 4].”
MethodSteyerberg, E. W. (2009) · Statistics for Biology and Health · doi:10.1007/978-0-387-77244-8 · Cited by 1,491
Everything you always wanted to know about evaluating prediction models (but were too afraid to ask)
Vickers, A. J., & Cronin, A. M. (2010) · Urology · doi:10.1016/j.urology.2010.06.019 · Cited by 112
Self-citation
Cited by
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Self-citationA calibration hierarchy for risk models was defined: from utopia to empirical data
Van Calster, B., Nieboer, D., Vergouwe, Y., De Cock, B., Pencina, M. J., & Steyerberg, E. W. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.12.005 · Cited by 910
Ankerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J., et al. (2014) · Urology · doi:10.1016/j.urology.2014.02.035 · Cited by 236
Self-citation
Metadata
- Authors
- Ankerst, D. P., Boeck, A., Freedland, S. J., Thompson, I. M., Cronin, A. M., Roobol, M. J., Hugosson, J., Stephen Jones, J., Kattan, M. W., Klein, E. A., Hamdy, F., Neal, D., Donovan, J., Parekh, D. J., Klocker, H., Horninger, W., Benchikh, A., Salama, G., Villers, A., Moreira, D. M., Schröder, F. H., Lilja, H., & Vickers, A. J.
- Venue
- World Journal of Urology
- Published
- 2011-12-31
- Volume
- 30
- Issue
- 2
- Pages
- 181-187
- ISSN
- 0724-4983 (ISSN-L)
- 1433-8726
- OpenAlex
- W1990838727
- Cited by
- 65
- References
- 5
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. https://app.cochat.ai/papers/10.1007/s00345-011-0818-5
- The paper
- Ankerst, D. P., Boeck, A., Freedland, S. J., Thompson, I. M., Cronin, A. M., Roobol, M. J., Hugosson, J., Stephen Jones, J., Kattan, M. W., Klein, E. A., Hamdy, F., Neal, D., Donovan, J., Parekh, D. J., Klocker, H., Horninger, W., Benchikh, A., Salama, G., Villers, A., . . . Vickers, A. J. (2012). Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World Journal of Urology. https://doi.org/10.1007/s00345-011-0818-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.